ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $477,285 | +69.9% | 23,500 | +52.6% | 0.00% | – |
Q1 2023 | $280,896 | -78.2% | 15,400 | -75.3% | 0.00% | -100.0% |
Q4 2022 | $1,288,364 | +475.2% | 62,300 | +200.1% | 0.00% | – |
Q4 2018 | $224,000 | -29.3% | 20,758 | -8.8% | 0.00% | – |
Q3 2018 | $317,000 | -11.5% | 22,761 | -22.2% | 0.00% | -100.0% |
Q2 2018 | $358,000 | -20.8% | 29,258 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $452,000 | – | 29,258 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |